SEC Form 4 · accession 0001013606-16-000240
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
May 23, 2016
Accepted (ET)
May 25, 2016 · 2:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 23, 2016 | A | 17,699 | $0.00 | A | 670,276 | D | |
| Common StockF2 | May 23, 2016 | F | 6,652 | $0.00 | D | 663,624 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on May, 22, 2014. 33% percent of the shares subject to this award vested upon one year of service.
- F2Withholding of shares to satisfy statutory tax withholding obligations related to the vested shares. The Reporting Person made a withholding election on May 23, 2016.
Remarks
The reporting person's beginning share balance includes a number of shares issued under the company's Employee Stock Purchase Plan not previously reported to the Securities and Exchange Commission as the number of share was deemed immaterial by the company.